News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
343,397 Results
Type
Article (17284)
Company Profile (309)
Press Release (325804)
Section
Business (104217)
Career Advice (396)
Deals (19558)
Drug Delivery (39)
Drug Development (59333)
Employer Resources (41)
FDA (7923)
Job Trends (7091)
News (187505)
Policy (14170)
Tag
Academia (1145)
Alliances (26700)
Alzheimer's disease (843)
Antibody-drug conjugate (ADC) (70)
Approvals (7892)
Artificial intelligence (86)
Bankruptcy (177)
Best Places to Work (6289)
Biotechnology (254)
Breast cancer (150)
Cancer (1121)
Cardiovascular disease (80)
Career advice (327)
CAR-T (87)
Cell therapy (244)
Clinical research (47461)
Collaboration (374)
Compensation (157)
COVID-19 (1373)
C-suite (86)
Cystic fibrosis (79)
Data (1182)
Diabetes (108)
Diagnostics (2642)
Earnings (42549)
Events (57591)
Executive appointments (300)
FDA (8409)
Funding (349)
Gene therapy (181)
GLP-1 (361)
Government (1407)
Healthcare (8771)
Infectious disease (1422)
Inflammatory bowel disease (100)
Interviews (80)
IPO (10644)
Job creations (1135)
Job search strategy (284)
Layoffs (222)
Legal (2357)
Lung cancer (169)
Lymphoma (75)
Manufacturing (112)
Medical device (5124)
Medtech (5126)
Mergers & acquisitions (9123)
Metabolic disorders (302)
Neuroscience (1120)
NextGen Class of 2024 (2665)
Non-profit (1107)
Northern California (1315)
Obesity (157)
Opinion (109)
Parkinson's disease (85)
Patents (83)
People (30410)
Phase I (16196)
Phase II (21802)
Phase III (14569)
Pipeline (448)
Postmarket research (1067)
Preclinical (6812)
Radiopharmaceuticals (223)
Rare diseases (234)
Real estate (1876)
Regulatory (11328)
Research institute (1171)
Southern California (1182)
Startups (2109)
United States (10895)
Vaccines (253)
Weight loss (90)
Date
Today (11)
Last 7 days (123)
Last 30 days (1352)
Last 365 days (25436)
2025 (65)
2024 (25920)
2023 (28620)
2022 (33636)
2021 (35257)
2020 (30941)
2019 (21729)
2018 (15951)
2017 (18109)
2016 (15269)
2015 (18758)
2014 (13777)
2013 (9993)
2012 (10272)
2011 (10710)
2010 (10304)
Location
Africa (221)
Asia (21719)
Australia (3476)
California (2991)
Canada (1160)
China (258)
Colorado (124)
Connecticut (142)
Europe (46013)
Florida (380)
Georgia (91)
Illinois (182)
Indiana (89)
Maryland (410)
Massachusetts (2327)
Michigan (91)
Minnesota (127)
New Jersey (823)
New York (842)
North Carolina (541)
Northern California (1315)
Ohio (93)
Pennsylvania (624)
South America (409)
Southern California (1182)
Texas (385)
Washington State (316)
343,397 Results for "expression therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Expression Therapeutics Announces Promising Phase 1 Results for Groundbreaking Hemophilia A Gene Therapy at ASH
December 11, 2024
·
4 min read
Press Releases
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
November 19, 2024
·
2 min read
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
Drug Development
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
Omega Therapeutics, Inc. announced the presentation of new preclinical data demonstrating durable and tunable bidirectional regulation of gene expression in cellular models at the pre-transcriptional level at the American Society of Gene and Cell Therapy 27th Annual Meeting, taking place in Baltimore, Maryland, May 7 – 11.
May 8, 2024
·
6 min read
BioMidwest
Daicel Arbor Biosciences launches new myTXTL® kits to accelerate protein expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering.
June 25, 2024
·
2 min read
BioMidwest
Express Scripts enhances strategies to support access to care at independent pharmacies
Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
May 23, 2024
·
3 min read
Press Releases
Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test
December 23, 2024
·
7 min read
Press Releases
Celltheon Launches Revolutionary OmniCHO™ Transient Expression Kit
October 23, 2024
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
Alligator Bioscience AB and Aptevo Therapeutics today announced positive interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 for the treatment of solid tumors likely to express the tumor antigen 5T4.
March 7, 2024
·
8 min read
1 of 34,340
Next
